J0567 HCPCS Level II code: Injection, cerliponase alfa, 1 mg
J0567 is the HCPCS code for “Injection, cerliponase alfa, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0567Injection, cerliponase alfa, 1 mg
Short description: Inj., cerliponase alfa 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0567 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2019
Where J0567 sits
- 1J codesDrugs administered other than orally
- 2Active code J0567Injection, cerliponase alfa, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0567 mean?
J0567 is the HCPCS code for “Injection, cerliponase alfa, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0567?
CMS lists J0567’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0567
All J codesJ0520Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mgJ0525Injection, cefotetan disodium, 10 mgJ0528Injection, fosfomycin disodium, 20 mgJ0558Injection, penicillin g benzathine and penicillin g procaine, 100,000 unitsJ0561Injection, penicillin g benzathine, 100,000 unitsJ0565Injection, bezlotoxumab, 10 mgJ0570Buprenorphine implant, 74.2 mgJ0571Buprenorphine, oral, 1 mgJ0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphineJ0573Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphineJ0574Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphineJ0575Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine